'Healthy' man, 36, told he'll die from cancer after terrifying warning sign at 3am
George Dudnik, 36, was told he was far too young and fit to be diagnosed with cancer – but after a series of terrifying ...
Little-known cancer symptom appeared on man's face at 3am before stage four diagnosis
George Dudnik has been given a stage four lung cancer diagnosis and has been bluntly told he will die from the disease – and ...
'I woke with terrifying symptom at 3am – now I have stage four cancer death sentence'
EXCLUSIVE: A yoga teacher and health enthusiast has been diagnosed with stage four lung cancer – and he said his first ...
Scientists Discover How To Reactivate Cancer’s Dormant “Kill Switch”
The discovery could pave the way for a groundbreaking RNA-based multi-cancer treatment. Alternative RNA splicing functions ...
Pulmonology Advisor18h
Lung Cancer Rates Vary Worldwide by Subtype, With Adenocarcinoma as Main Subtype
Lung cancer rates vary by subtype and adenocarcinoma incidence worldwide, likely due to differences in air pollution, smoking, and generational patterns.
University of California1d
Breathing new life: Working toward an inhalable gene therapy for cystic fibrosis
Although cystic fibrosis is a single gene mutation, there are more than 1,000 different ways the CFTR gene can mutate in ...
Targeted Oncology2d
Treatment Decision-Making for Metastatic NSCLC With a ROS1 Alteration
Panelists discuss treatment decision-making for metastatic non–-small cell lung cancer (NSCLC) with a ROS1 alteration, ...
TipRanks on MSN2d
Bristol Myers’ treatment of small cell lung cancer gets FDA orphan designation
Bristol Myers (BMY)’ treatment of small cell lung cancer, atigotatug plus nivolumab fixed dose combination, received FDA ...
Targeted Oncology6d
Velcheti Evaluates Activity of Repotrectinib for ROS1 Fusion–Positive NSCLC
During a Case-Based Roundtable® event, Vamsidhar Velcheti, MD, discussed the TRIDENT-1 trial and practical considerations for ...